Clinical Trials Browser

Leukemia × tazemetostat × 1 year × Clear all

NCT05983965 2026-04-17

Study of Tazemetostat in Lymphoid Malignancies

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, T-Cell